The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o
โฆ LIBER โฆ
Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitor
โ Scribed by H. P. Ludin; F. Bass-Verrey
- Publisher
- Springer
- Year
- 1976
- Tongue
- English
- Weight
- 602 KB
- Volume
- 38
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Comparative study of selegiline plus L-d
โ
Timothy Brannan; Dr. Melvin D. Yahr
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 383 KB
๐ 1 views
Long-term treatment response and fluorod
โ
Dr. Torbjoern G. Nygaard; Hirohide Takahashi; Gary A. Heiman; Barry J. Snow; Sta
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 541 KB
Long-term benefits of rivastigmine in de
โ
Werner Poewe; Erik Wolters; Murat Emre; Marco Onofrj; Chuanchieh Hsu; Sibel Teki
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 110 KB
## Abstract In patients with dementia associated with Parkinson's disease (PD), the efficacy and safety of rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, were previously demonstrated in a 24โweek doubleโblind placeboโcontrolled trial. Our objective was to determine wh
The effect of long-term treatment with d
โ
D. E. Dluzen; J. L. McDermott
๐
Article
๐
1991
๐
Springer
๐
English
โ 867 KB
Long-term follow-up of a prospective ran
โ
S. P. Misra; M. Dwivedi; L.-E. Hammarstrom
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 273 KB
๐ 2 views
Long-term follow-up of a prospective ran
โ
Dr. L.-E. Hammarstrรถm; T. Holmin; H. Stridbeck; I. Ihse
๐
Article
๐
1995
๐
John Wiley and Sons
๐
English
โ 710 KB